AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Ovoca Bio Plc

Director's Dealing Jul 15, 2024

1970_dirs_2024-07-15_21578c49-14c3-4897-8788-c5e27f86e506.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3002W

Ovoca Bio PLC

15 July 2024

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Timothy McCutcheon

2

Reason for the notification

a)

Position/status

Non-Executive Director, PDMR

b)

Initial Notification Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

b)

LEI

213800ST2AK5XQ1O5207

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary Shares of nominal value €0.125 each

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
0.85 pence per share 19,506,203

d)

Aggregated information

- Aggregated volume

- Price

N/A (Single Transaction)

e)

Date of the transaction

12 July 2024

f)

Place of the transaction

Outside of a trading venue

g)

Additional Information

Following this transaction, Mr McCutcheon has an interest in 19,506,203 Ordinary Shares in Ovoca Bio plc, or 23.92% of the Issued Share Capital of the Company (excl. Treasury Shares)

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kirill Golovanov

2

Reason for the notification

a)

Position/status

Chief Executive Officer, PDMR

b)

Initial Notification Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

b)

LEI

213800ST2AK5XQ1O5207

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary Shares of nominal value €0.125 each

ISIN: IE00B4XVDC01

b)

Nature of the transaction  

Disposal of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
0.85 pence per share 19,506,203

d)

Aggregated information

- Aggregated volume

- Price

N/A (Single Transaction)

e)

Date of the transaction

12 July 2024

f)

Place of the transaction

Outside of a trading venue

g)

Additional Information

Following this transaction, Mr. Golovanov no longer holds any Ordinary Shares in Ovoca Bio plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEAKXAFALLEFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.